Skip to main content
. Author manuscript; available in PMC: 2020 Oct 12.
Published in final edited form as: Laryngoscope. 2019 Apr 12;130(2):405–412. doi: 10.1002/lary.27994

TABLE III.

Five-Year Hazard Ratio of All-Cause Mortality Among Tracheal Squamous Cell Carcinoma Patients According to Treatment Modality by Localized and Advanced Staging.

Characteristic Localized (n = 248) Regional Extension (n = 222)


Adjusted Cox HR* (95% CI) P Value Adjusted Cox HR* (95% CI) P Value

Treatment modality
 No treatment  1.00 (Ref)  1.00 (Ref)
 Limited surgery  0.56 (0.29–1.07) 0.08  0.82 (0.38–1.78) 0.62
 Curative surgery  0.38 (0.18–0.79) 0.01  0.35 (0.17–0.76) 0.01
 Limited surgery + AT  0.53 (0.28–1.02) 0.06  0.38 (0.21 −0.7)  <0.01
 Cur surgery + AT  0.39 (0.17–0.86) 0.02  0.32 (0.16–0.66)  <0.01
 RT  0.72 (0.39–1.33) 0.29  0.48(0.29–0.81) 0.01
 CRT  0.55 (0.3–1.00) 0.05  0.34 (0.21 −0.56)  <0.01
*

Adjusted for sex, age, insurance type, comorbidities, treatment facility type, and palliative treatment.

CI = confidence interval; HR = hazard ratio.